report
Aier Eye Hospital Group to face slower revenue growth in 2025-26: report
Aier Eye Hospital Group to face slower revenue growth in 2025-26: report
Weaker demand for services and economic uncertainties pose key challenges.
China’s digital health sector poised for growth amidst AI developments
However, data security must be upheld.
Antibiotics market to grow by $18.22b by 2029
Key drivers include strategic alliances and mergers amongst pharmaceutical firms.
Global assistive technology market to grow by $6.3b by 2029
Its expansion is driven by the rising number of orthopaedic and neurological disorders.
Vietnam’s medical device market to rise at 8.4% CAGR through 2029
Thanks to strong economic performance amidst growing political risks.
Cochlear implants market to be valued at $4.73b by 2030
Thanks to a rising prevalence of hearing loss and awareness of rehabilitation options.
Wearable tech is your heart’s new best friend
One specialist clinic in Singapore uses a Holter patch to cut face-to-face appointments.
What lies ahead for neuroendoscopy devices?
The increasing adoption of minimally invasive surgeries is fueling the sector.
Telehealth and telemedicine market to hit $180.86b by 2030
Its growth is attributed to the growing geriatric and medically underserved populations.
Global wrist wearables market projected to double by 2030
One notable driver includes improvements in sensor technology.
China’s CRDMO firms gain temporary reprieve with Biosecure act delay
The act’s postponement opens opportunities to expand overseas investment.
Global nocturia market to reach $8.5b by 2034
Its growth is attributed to an ageing population and a rise in chronic diseases.
Global wound care devices market to be valued at $4b by 2032
A key driver is the rising prevalence of chronic wounds.
Bumrungrad Hospital to see ‘soft’ revenue growth for Q1: report
A report said that its single-campus model limits its ability to benefit from foreign tourists.
7MM parkinson’s disease market to hit $7.9b by 2033
The number of diagnosed cases is expected to rise to 3.1 million.
Interventional oncology market to be valued at $4.24b by 2029
One key driver is the increasing burden of cancer.
Australia’s pharmaceutical market to see 6% five-year CAGR growth: report
Government measures are expected to challenge pharmaceutical firms.